Tag: HALO

  • Hot Runners: Halozyme Therapeutics (NASDAQ:HALO), Alcoa Inc. (NYSE:AA), Splunk Inc. (NASDAQ:SPLK), AT&T Inc. (NYSE:T)

    Halozyme Therapeutics, Inc. (NASDAQ:HALO) Hylenex treatment met the main goal of a trial in which a recombinant and a new formulation of the therapy were assessed. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock opened today at $13.20 and is currently trading at $12.61. The stock showed a negative weekly performance of -10.56%.

    Alcoa Inc. (NYSE:AA) will curtail 147,000 metric tons of smelting capacity at its Sao Luis and Pocos de Caldas smelters due to falling aluminium prices and rising costs. Alcoa Inc. (NYSE:AA) stock opened at $12.52, in current trading session and currently is at $12.64, by gaining 1.28%. The 52 week range of $7.63 – $12.75. Company’s market capitalization is $13.62 billion.

    Splunk Inc. (NASDAQ:SPLK), provider of the leading software platform for real-time operational intelligence, today announced version 3.0 of the Splunk® App for Microsoft Exchange. Splunk Inc. (NASDAQ:SPLK), stock is currently trading at $71.67. The EPS of the stock is -63.00. Company’s market capitalization is $7.66 billion.

    The board of directors of AT&T Inc. (NYSE:T) authorized the repurchase of up to 300 million shares, representing approximately 6% of AT&T common shares outstanding, with no expiration date. This authorization is in addition to three other 300 million share repurchase authorizations approved by the board of directors in December 2010, July 2012 and March 2013. AT&T Inc. (NYSE:T) stock opened the session at $72.93, and now is at $71.51. The 52 week range of the AT&T Inc. (NYSE:T) stock remained $38.60 – $106.15 and the day range was $70.44 – $72.93.